Tcg Crossover Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $612 Million distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $62.4M, Xencor Inc with a value of $56.4M, Cogent Biosciences, Inc. with a value of $54.3M, Centessa Pharmaceuticals PLC with a value of $48.4M, and Ocular Therapeutix, Inc with a value of $45.4M.
Examining the 13F form we can see an decrease of $158M in the current position value, from $771M to 612M.
Tcg Crossover Management, LLC is based out at Palo Alto, CA
Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.
